tradingkey.logo

Avalon Globocare Corp

ALBT
1.260USD
-0.020-1.56%
Close 12/24, 13:00ETQuotes delayed by 15 min
5.16MMarket Cap
LossP/E TTM

Avalon Globocare Corp

1.260
-0.020-1.56%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Avalon Globocare Corp

Currency: USD Updated: 2025-12-24

Key Insights

Avalon Globocare Corp's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 155/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Avalon Globocare Corp's Score

Industry at a Glance

Industry Ranking
155 / 206
Overall Ranking
472 / 4562
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Avalon Globocare Corp Highlights

StrengthsRisks
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.33M.
Overvalued
The company’s latest PE is -0.16, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 25.38K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.97.

Financial Health

Currency: USD Updated: 2025-12-24

The current financial score of Avalon Globocare Corp is 5.71, ranking 191/206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 350.10K, representing a year-over-year increase of 1.43%, while its net profit experienced a year-over-year increase of 84.86%.

Score

Industry at a Glance

Previous score
5.71
Change
0

Financials

3.39

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

10.00

Operational Efficiency

2.83

Growth Potential

5.26

Shareholder Returns

7.07

Avalon Globocare Corp's Company Valuation

Currency: USD Updated: 2025-12-24

The current valuation score of Avalon Globocare Corp is 6.79, ranking 149/206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.16, which is -29.54% below the recent high of -0.11 and -2712.20% above the recent low of -4.38.

Score

Industry at a Glance

Previous score
6.79
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 155/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-24

No earnings forecast score is currently available for Avalon Globocare Corp. The Healthcare Equipment & Supplies industry's average is 7.77.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-24

The current price momentum score of Avalon Globocare Corp is 4.87, ranking 187/206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.73 and the support level at 0.84, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
5.30
Change
-0.43

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.048
Neutral
RSI(14)
44.286
Neutral
STOCH(KDJ)(9,3,3)
57.628
Buy
ATR(14)
0.204
High Vlolatility
CCI(14)
-12.979
Neutral
Williams %R
57.188
Sell
TRIX(12,20)
-1.596
Sell
StochRSI(14)
84.999
Overbought
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
1.228
Buy
MA10
1.176
Buy
MA20
1.316
Sell
MA50
1.706
Sell
MA100
2.024
Sell
MA200
2.799
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-24

The current institutional shareholding score of Avalon Globocare Corp is 3.00, ranking 135/206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 1.25%, representing a quarter-over-quarter decrease of 10.10%. The largest institutional shareholder is The Vanguard, holding a total of 25.38K shares, representing 0.60% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Lu (Wenzhao)
238.93K
+0.00%
Jin (David)
103.00K
--
Li (Meng)
34.33K
+0.00%
The Vanguard Group, Inc.
Star Investors
1.58K
--
Geode Capital Management, L.L.C.
9.34K
--
Tauzin (Wilbert J II)
1.04K
--
Tower Research Capital LLC
241.00
--
Citi Investment Research (US)
951.00
--
BofA Global Research (US)
113.00
+6.60%
UBS Financial Services, Inc.
4.20K
+64.05%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-24

The current risk assessment score of Avalon Globocare Corp is 3.02, ranking 133/206 in the Healthcare Equipment & Supplies industry. The company's beta value is -0.10. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.02
Change
0
Beta vs S&P 500 index
-0.10
VaR
+10.64%
240-Day Maximum Drawdown
+91.86%
240-Day Volatility
+138.30%

Return

Best Daily Return
60 days
+23.91%
120 days
+30.84%
5 years
+316.95%
Worst Daily Return
60 days
-24.63%
120 days
-24.63%
5 years
-33.67%
Sharpe Ratio
60 days
-1.66
120 days
-0.80
5 years
+0.03

Risk Assessment

Maximum Drawdown
240 days
+91.86%
3 years
+98.46%
5 years
+99.54%
Return-to-Drawdown Ratio
240 days
-0.69
3 years
-0.33
5 years
-0.20
Skewness
240 days
+0.46
3 years
+13.93
5 years
+15.55

Volatility

Realised Volatility
240 days
+138.30%
5 years
+159.19%
Standardised True Range
240 days
+29.83%
5 years
+346.83%
Downside Risk-Adjusted Return
120 days
-117.76%
240 days
-117.76%
Maximum Daily Upside Volatility
60 days
+105.55%
Maximum Daily Downside Volatility
60 days
+84.47%

Liquidity

Average Turnover Rate
60 days
+48.88%
120 days
+26.07%
5 years
--
Turnover Deviation
20 days
-97.46%
60 days
-74.63%
120 days
-86.47%

Peer Comparison

Healthcare Equipment & Supplies
Avalon Globocare Corp
Avalon Globocare Corp
ALBT
4.02 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Avalon Globocare Corp?

The TradingKey Stock Score provides a comprehensive assessment of Avalon Globocare Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Avalon Globocare Corp’s performance and outlook.

How do we generate the financial health score of Avalon Globocare Corp?

To generate the financial health score of Avalon Globocare Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Avalon Globocare Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Avalon Globocare Corp.

How do we generate the company valuation score of Avalon Globocare Corp?

To generate the company valuation score of Avalon Globocare Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Avalon Globocare Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Avalon Globocare Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Avalon Globocare Corp.

How do we generate the earnings forecast score of Avalon Globocare Corp?

To calculate the earnings forecast score of Avalon Globocare Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Avalon Globocare Corp’s future.

How do we generate the price momentum score of Avalon Globocare Corp?

When generating the price momentum score for Avalon Globocare Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Avalon Globocare Corp’s prices. A higher score indicates a more stable short-term price trend for Avalon Globocare Corp.

How do we generate the institutional confidence score of Avalon Globocare Corp?

To generate the institutional confidence score of Avalon Globocare Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Avalon Globocare Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Avalon Globocare Corp.

How do we generate the risk management score of Avalon Globocare Corp?

To assess the risk management score of Avalon Globocare Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Avalon Globocare Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Avalon Globocare Corp.
KeyAI